Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. (8th October 2012)

• Record Type: Journal Article
• Authors: Yang, Yong; Wolfram, Joy; Boom, Kathryn; Fang, Xiaohong; Shen, Haifa; Ferrari, Mauro
• Is Part Of: Cell biochemistry and function. Volume 31:Number 5(2013:Jul.)
• Page Start: 374
• Page End: 379
• Publication Date: 2012-10-08
• Subjects: Cytochemistry -- Periodicals; Cell metabolism -- Periodicals; Biochemistry -- Periodicals; Cytology -- Periodicals; 572
• DOI: 10.1002/cbf.2905
• Languages: English
• ISSNs: 0263-6484

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>The flavanone hesperetin is known to decrease basal glucose uptake, although the inhibitory mechanism is largely unknown. Here, we used MDA‐MB‐231 breast cancer cells to investigate the molecular pathways affected by hesperetin. The results indicate that the suppression of glucose uptake is caused by the down‐regulation of glucose transporter 1 (GLUT1). Hesperetin was also found to inhibit insulin‐induced glucose uptake through impaired cell membrane translocation of glucose transporter 4 (GLUT4). In addition, the phosphorylation of the insulin receptor‐beta subunit (IR‐beta) and Akt was suppressed. Hesperetin also decreased cellular proliferation, which is likely due to the inhibition of glucose uptake. Cancer cells are highly dependent on glucose and hesperetin may, therefore, have potential application as an anticancer agent. Copyright © 2012 John Wiley &amp; Sons, Ltd.</p> </abstract>